GL1X · GenesisL1 explorer

MolNFT v1 · #378291 · protein

AlphaFold monomer V2.0 prediction for probable dual-specificity RNA methyltransferase rlmn (C1A949)

C1A949: “AlphaFold monomer V2.0 prediction for probable dual-specificity RNA methyltransferase rlmn (C1A949)”. 2 pockets (best druggability 0.81). MolNFT v1 #378291 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

Accession
C1A949
Type
protein
Length
360 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x356A98300827Dd8A16B914ED13C2114FD83b1072
Molecule
Probable dual-specificity RNA methyltransferase rlmn
UniProt
C1A949
Pockets
2 · best druggability 0.81

Structure

1 distinct chain · 37% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProbable dual-specificity RNA methyltransferase rlmnprotein36037% helix, 19% strandC1A949

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16080.810.8662empty
21320.400.7518empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.